2023 Annual Scientific Meeting
Get the most out of the Annual Scientific Meeting by ANZCHOG by registering for the pre-ASM workshops. Please see below for more information on the workshops.
ANZCHOG TACTIC (Transplantation & Cellular Therapy in Children) Group Annual Meeting (closed meeting)
Wednesday 23 August 1300 – 1700 at Perth Children’s Hospital
TUE 22 - THU 24 AUG
A three-day course featuring an invited international speaker and in-depth training on paediatric CNS tumours.
When:
Starts Tuesday 22 August
Where:
There are two locations for this course.
Day 1
Tuesday 22 August
1:00pm – 5:00pm
Department of Radiation Oncology
Sir Charles Gairdner Hospital
SCGH Cancer Care Room 1, DD Block
1 Hospital Avenue
Nedlands, Perth 6009
Western Australia
Day 2 & 3
Wednesday 23 & Thursday 24 August:
The Westin, Perth
Prof Arnold Paulino,
MD Anderson
Texas, USA
| TUESDAY 22nd August 2023 | Location | |
|---|---|---|
|
1230 |
PROTC Workshop, Cancer Care Room 1 & 2, DD Block, Ground Floor Sir Charles Gairdner Hospital |
|
|
1300-1315 |
CSI Case Study A/Prof J. Dass |
CCMR1 |
|
1315-1330 |
CSI Planning C. Wan |
|
|
1330-1345 |
CSI Junctions Dr M. Skorska |
|
|
1345-1355 |
CSI Side Effects A/Prof J. Dass |
|
|
1355-1400 |
Q&A |
|
|
1400-1415 |
TBI Case Study A/Prof J. Dass |
|
|
1415-1435 |
TBI Planning C. Wan |
|
|
1435-1450 |
TBI Physics Aspects G. Neveri |
|
|
1450-1455 |
TBI Side Effects A/Prof J. Dass |
|
|
1455-1500 |
Q&A |
|
|
1500-1515 |
Afternoon tea |
|
|
1515-1615 |
Proton Therapy Prof. A. Paulino |
|
|
1615-1630 |
Introduction to stereotactic radiotherapy using Cyberknife M6 System Dr J. Dass |
|
|
1630-1640 |
Cyber Knife Demonstration Group 1 Dr M. Skorska |
|
|
1640-1650 |
Cyber Knife Demonstration Group 2 Dr M. Skorska |
Wandoo |
| Wednesday 23rd August 2023 | |||
|---|---|---|---|
|
|
Westin Hotel |
||
|
0830-0900 |
Registration open |
||
|
0900-1030 |
Paediatric CNS Tumours – Part 1 |
||
|
0900-1000 |
Challenges and differences between adults and children Dr Frank Saran |
||
|
1000-1030 |
Introduction to molecular biology of paediatric tumours Prof Nick Gottardo |
||
|
1030-1100 |
Morning tea |
||
|
1100-1200 |
Paediatric CNS Tumours – Part 2 |
||
|
1100-1130 |
CNS tumours – Radiotherapy (Medulloblastoma and GCT) Dr Alison Salkeld |
||
|
1130-1200 |
Gliomas/Ependymomas/Craniopharyngiomas Dr Michelle Li |
||
|
1200-1300 |
Lunch |
||
|
1300-1430 |
Paediatric Solid Tumours – Part 1 |
||
|
1300-1330 |
Ewing’s Sarcoma Robyn Cheuk |
||
|
1330-1400 |
Rhabdomyosarcoma Chris Harrington |
||
|
1400-1430 |
Lymphoma Dr Jennifer Chard |
||
|
1430-1500 |
Afternoon tea |
||
|
1500-1700 |
Paediatric Solid Tumours – Part 2 |
||
|
1500-1530 |
Wilms tumours Prof Arnold Paulino |
||
|
1530-1630 |
Neuroblastoma Dr Greg Wheeler |
||
|
1630 |
Welcome drinks |
||
| Thursday 24th August 2023 | |||
|---|---|---|---|
|
|
Westin Hotel |
||
|
0900-0940 |
RT associated late toxicity Dr Greg Wheeler |
||
|
0940-1020 |
Palliative Care Management with Radiotherapy Ben Hindson |
||
|
1020-1035 |
Morning tea |
||
|
1035-1115 |
Invited Speaker - MD Anderson Cancer Centre Dr Arnold Paulino |
||
|
1135-1155 |
RANZCR Paediatric Examiner’s Quarter (Trainees only) Dr Mandy Taylor |
||
|
1155-1225 |
Lunch break |
||
|
1230 |
ANZCHOG ASM commences 1230 sharp with Acknowledgement of Country Dance and plenary session with Dr Arnold Paulino "Proton Therapy in Paediatric Cancer: What is the Evidence?" |
||
WED 23 - THU 24 AUG
Both the Survivorship Workshops that are scheduled to take place on Wednesday 23 – Thursday 24 August have reached capacity. If you do wish to be added to a waitlist, please contact the ASM organisers via info@asm-anzchog.com
Wednesday 23 August 2023
Survivorship Workshop – Survivorship Day
1200-1700
Seminar Room 1, UWA, University Club, Entrance 1, Hackett Dr, Crawley WA 6009
Thursday 24 August 2023
Survivorship Workshop – Transition Day
0800-1100
Seminar Room 1, UWA, University Club, Entrance 1, Hackett Dr, Crawley WA 6009
Transport
For those requiring transport to the workshop/s (interstate attendees or those staying at The Westin), a chartered bus has been arranged to provide complimentary transportation to and from the workshops. The pickup and drop-off location will be at The Westin Perth. To reserve a spot on the bus, please email: wacog@cancerwa.asn.au
THU 24 AUG
When: Thursday 24 August
Where: Westin, Perth
| Program | |
|---|---|
|
0800-0815 |
Welcome ANZCHOG Board Chair Prof Nick Gottardo |
|
0815-0830 |
EViQ Update Rachel Edwards |
|
0830-0905 |
Relationships and Connection with Children Ranita Sidhu |
|
0905-0945 |
Transplant-Associated Thrombotic Microangiopathy Maddie Gilsenan |
|
0945-1015 |
Morning tea |
|
1015-1045 |
Creating a strong research question Prof Natalie Bradford |
|
1045-1115 |
Abstract Presentations Exploring health behaviours, self-efficacy and persistent symptoms in survivors of childhood cancer Natalie Bradford, Queensland University of Technology “Engage”: A survivorship program to improve young survivors’ health-related self-efficacy Dr Jordana McLoone, UNSW Sydney; Sydney Children's Hospital Paediatric Oncology Workforce Survey: Addressing the Challenges and Opportunities Dr Karin, Plummer, Griffith University "Burn Out" - An opportunity for action and change Jayne Harrison, Children's Cancer Centre, Royal Childrens Hospital |
|
1115-1200 |
Workshop – Being at our Best. Managing the challenges of our chosen vocation Dr Julie Stone |
Key for Program
- Program
- Breaks
- Partner session
- Social function
- Ballroom 1+2
- Exhibition
- Mallee / Eucalypt
|
Room TBC |
|||
|
0730-1130 |
ANZCHOG TACTIC (Transplantation & Cellular Therapy in Children) Group Annual Meeting (closed meeting) |
||
|
Ballroom 1 & 2 |
|||
|
1230-1300 |
Opening Ceremony and Acknowledgement of Country |
||
|
1300-1400 |
Plenary 1 - Radiation Oncology
Chairs - Tom Walwyn/Josh Dass Proton Therapy in Paediatric Cancer: What is the Evidence? Dr Arnold Paulino, University Of Texas MD Anderson Cancer Center, United States Speaker involvement made possible thanks to the support from SCGH RadOnc |
||
|
1400-1500 |
Plenary 2 - Survivorship
Chairs - Tom Walwyn/Josh Dass Future state of guidelines for survivors of paediatric /AYA cancer therapy: personalisation, evolving evidence and the survivorship clinician Dr Matthew Ehrhardt, St Jude Children's Research Hospital, United States Speaker involvement made possible thanks to the support from  |
||
|
Ballroom 3 |
|||
|
1500-1530 |
Afternoon tea - Trade Display and Poster Viewing |
||
|
Ballroom 1 & 2 |
|||
|
1530-1700 |
ANZCHOG Clinical Trials Update Chair - Annie Ryan/Santosh Valvi |
||
|
1700-1800 |
ANZCHOG 2023 Best Abstract Presentations Chairs - Raelene Endersby/Siobhan Cross Australasian Methylation Array Profiling – Evolution beyond Accreditation Dr Christine White, Victorian Clinical Genetics Services A holistic approach to psychosocial support for parents and families of paediatric cancer patients in Aotearoa New Zealand: The National Child Cancer Counselling Network Assoc Prof Kirsty Ross, Massey University Development of Juvenile Models of Childhood Cancers Reveals Age-Specific Immune Signatures in Early Life Tumor Microenvironment Dr Omar Elaskalani, Telethon Kids Institute & University Of Western Australia MARVEL-PIC Minimising Adverse Drug Reactions and Verifying Economic Legitimacy – A Pre-emptive Pharmacogenomics Program in Paediatric Oncology Ms Claire Moore, Murdoch Children's Research Institute Pulmonary complications in children following Haematopoietic stem cell transplant Dr Hannah Walker, The Royal Children's Hospital Melbourne Neuroinflammation Drives Acute Lymphoblastic Leukaemia Therapy-Induced Adverse Effects Dr Hana Starobova, The University of Queensland |
||
|
Ballroom 3 |
|||
|
1800-2000 |
|||
Key for Program
- Program
- Breaks
- Partner session
- Social function
- Ballroom 1+2
- Exhibition
- Mallee / Eucalypt
|
0730-0830 |
Ballroom 1 |
Ballroom 2 |
|
|
Alexion Breakfast |
0700-0830 Clinical Research Professionals Breakfast (Closed meeting) |
||
|
A new therapeutic option in NF1 PN Prof Jordan Hansford Brought to you by Alexion 
|
Brought to you by Minderoo
|
||
|
Ballroom 1 & 2 |
|||
|
0900-1000 |
|||
|
Plenary 3 - Solid Tumour
Chairs - Annie Ryan/Toby Trahair Current Challenges and Treatments for Relapsed Neuroblastoma Dr Lucas Moreno, Vall D'hebron Hospital, Spain Speaker involvement made possible thanks to the support from 
|
|||
|
Ballroom 3 |
|||
|
1000-1030 |
Morning Tea - Trade Display and Poster Viewing |
||
|
Ballroom 1 & 2 |
|||
|
1030-1130 |
Plenary 4 - Leukaemia
Chairs - Rishi Kotecha/Tina Carter Improving Global Childhood Cancer Outcomes through Advocacy, Policy, and Research Dr Sumit Gupta, The Hospital For Sick Children, Canada Speaker involvement made possible thanks to the support from  |
||
|
1130-1230 |
Plenary 5 - Haematology Chairs - Rishi Kotecha/Tina Carter Gene and targeted therapies in the Haemoglobinopathies – is a cure possible? Prof Joy Ho, Institute of Haematology, Royal Prince Alfred Hospital |
||
|
Ballroom 3 |
|||
|
1230-1330 |
Lunch - Trade Display and Poster Viewing |
||
|
Eucalypt & Mallee Room |
|||
|
1240-1325 |
Jazz Pharmaceuticals - Lunch Symposium
|
||
|
Endothelial-related disorders following HSCT:
focus on TA-TMA
Introduction Dr Shanti Ramachandran, Perth Children's Hospital Assoc Prof Adam Nelson, Sydney Children's Hospital Endothelial-related disorders following HSCT: focus on transplant-associated thrombotic microangiopathy (TA-TMA) Prof Sonata Jodele, Cincinnati Children's Hospital Medical Center, United States Q&A from audience Brought to you by Jazz Pharmaceuticals 
|
|||
|
1330-1500 |
Ballroom 1 |
Ballroom 2 |
Eucalypt & Mallee |
|
Concurrent 1 - Solid/CNS Clinical
Chairs - Marty Campbell/Enrica Tan Clinical Trial Development for Neuroblastoma Dr Lucas Moreno, Vall D'hebron Hospital, Spain Speaker involvement made possible thanks to the support from
Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion cancer: an extended follow-up Dr Hetal Dholaria, Perth Children's Hospital Prognostic Significance of Molecular Subgroups in the Survival Outcome for Children with Medulloblastoma in Malaysia Dr Revathi Rajagopal, Hospital Raja Permaisuri Bainun Making cancer therapy choices with a survivorship lens Dr Matthew Ehrhardt, St. Jude Children's Research Hospital, United States Speaker involvement made possible thanks to the support from |
Concurrent 2 - Leukaemia/Lymphoma
Chairs - Diane Hanna/Sarah Trinder Standard Risk ALL: Time to declare victory, or change the paradigm Dr Sumit Gupta, The Hospital For Sick Children, Canada Speaker involvement made possible thanks to the support from
Understanding the Morbidity and Mortality Associated With Cancer in Aboriginal and Torres Strait Islander Children Dr Jessica Buck, Telethon Kids Institute Incidence, cytogenetics and outcome in Polynesians with Pediatric Acute Myeloid Leukemia in New Zealand Dr Siobhan Cross, Waitaha Canterbury “It takes a village.” Improving childhood cancer survival in Papua New Guinea – A multi-disciplinary approach. Dr Sandra Staffieri, Royal Children's Hospital/Centre for Eye Research Australia Stage-specific changes in incidence and survival for childhood cancers in Australia, 2000-2017 Assoc Prof Danny Youlden, Cancer Council Queensland |
Concurrent 3 - Haematology Chairs - Lochie Teague/ Vanessa Verissimo New developments in Thalassemia management Prof Joy Ho, Institute of Haematology, Royal Prince Alfred Hospital Bleeding disorder of unknown cause (BDUC) - the most frequent mild bleeding tendency? Prof Ross Baker, Western Haematology and Oncology Clinics Survey outcome of immunisation route preference for persons with haemophilia in Australia Dr Tina Carter, Perth Children's Hospital Chronic Thrombocytopenia at [Australasian Tertiary Paediatric Hospital]: Finding Molecular Clues Dr Yasheer Haripersad, Perth Children's Hospital |
|
|
Ballroom 3 |
|||
|
1500-1530 |
Afternoon tea - Trade Display and Poster Viewing |
||
|
1530-1600 |
Ballroom 1 |
Ballroom 2 |
|
|
Recordati - Meet the Expert |
Alexion - Meet the Expert
|
||
|
Dinutuximab-Beta in High-Risk Neuroblastoma - experience and learnings at Vall d'Hebron Hospital, Barcelona
Dr Lucas Moreno, Vall D'hebron Hospital, Spain Brought to you by Recordati Rare Diseases / EUSA Pharma
|
An Expert Panel Discussion: Lymphohistiocytosis (HLH) – The Importance in Identifying Treatable Genetic Conditions
Dr Frank Alvaro, John Hunter Children’s Hospital Assoc Prof Kaustuv Bhattacharya, Sydney Children's Hospitals' Network Prof Maria Fuller Brought to you by Alexion
|
||
|
1600-1730 |
Ballroom 1 |
Ballroom 2 |
Eucalypt & Mallee |
|
Concurrent 4 - Solid/CNS
Chairs - Timothy Hassall/Neevika Manoharan For glioma: Towards cancer interception for gliomas in children adolescents and young adults Dr Uri Tabori, The Hospital for Sick Kids, Canada Clinical and preclinical considerations for the combination of radiotherapy, dordaviprone and paxalisib (NCT05009992) for the treatment of diffuse midline glioma Prof Matt Dun, The University Of Newcastle Australian Proton Therapy Experience Long-term Outcomes of Symptomatic Optic Pathway Glioma: 32-year Experience at a Single Western Australian Tertiary Paediatric Oncology Centre Dr Revathi Rajagopal, Hospital Raja Permaisuri Bainu Australian Proton Therapy Establishment Jordan Hansford, South Australian Health and Medical Research Institute |
Concurrent 5 - Leukaemia/Lymphoma/Translational Chairs - Deborah White/Vincent Kuek Novel therapies in B-cell lymphoma with potential for translation to the paediatric/adolescent setting Prof Chan Cheah, Breakthrough Haematology Profiling Of Minimal Residual Disease Opens Novel Avenues For Treatment In Down Syndrome Acute Lymphoblastic Leukaemia Dr Sebastien Malinge, Telethon Kids Institute - Cancer Centre High expression of DUX4 mRNA is a reliable indicator of DUX4-rearranged acute lymphoblastic leukaemia Ms Jacqueline Rehn, South Australian Health And Medical Research Institute Targeting Osteoclasts for Treatment of High-risk B-cell Acute Lymphoblastic Leukaemia Dr Laurence Cheung, Telethon Kids Institute and Curtin University Evaluation of an Enhanced Influenza Vaccination schedule in Immunocompromised Children undergoing Cancer Treatment Dr Sung Kai Chiu, Telethon Kids Institute |
Concurrent 6 - Haematology Chairs - Carly George/ Joy Ho Update on thrombosis management in children Prof Paul Monagle, Royal Children's Hospital Exciting new developments in the world of vascular malformations Dr Sue Russell, Kids Cancer Centre ANZ Platelet Group Update Dr Tina Carter, Perth's Children Hospital |
|
|
Ballroom 3 |
|||
|
1730-1900 |
Poster session
One Hundred Times Better, at Home in Our Own Beds: Implementation of Home Intravenous Hydration After Chemotherapy in Children with Cancer Rebekah Orford, Oncology Cytokines in Radioresistant Paediatric Craniopharyngiomas Enrica EK Tan, KK Women's and Children's Hospital Changing Trend of Transplant Donor for Primary Immunodeficiency Disorders and Outcome in Single Institution Mya Soe Nwe, KK Women's and Children's Hospital Role of glia maturation factor beta (GMFβ), an actin depolymerising factor, in neuroblastoma differentiation David Eisenstat, The Royal Children's Hospital Melbourne Bioluminescence Platform to Identify Stroma-mediated Chemoresistance in Leukaemia Rhiannon Panting, Telethon Kids Institute |
||
Key for Program
- Program
- Breaks
- Partner session
- Social function
- Ballroom 1+2
- Exhibition
- Mallee / Eucalypt
|
Boardroom 1 |
|||
|
0700-0830 |
ANZCHOG Psycho-Oncology Group Meeting (Closed Meeting)
|
||
|
Eucalypt & Mallee |
|||
|
0700-0830 |
Nurse Professional Breakfast (Closed Meeting) |
||
|
Ballroom 1 & 2 |
|||
|
0830-0930 |
Plenary 6 - Transplant & Cellular Therapy Chairs - Melissa Gabriel/Tim Prestidge Transplant-Associated Thrombotic Microangiopathy: Consensus Definitions and Up-to-Date Management Prof Sonata Jodele, Cincinnati Children’s Hospital Medical Center, United States Speaker involvement made possible thanks to the support from 
|
||
|
Ballroom 3 |
|||
|
0930-1000 |
Morning Tea - Trade Display and Poster Viewing |
||
|
Ballroom 1 & 2 |
|||
|
1000-1100 |
Plenary 7 - Solid/CNS Tumours
Chairs - Gordon Miles/Jordan Hansford Histone mutations in disease: tell a tale of a histone Dr Nada Jabado, McGill University, Canada Speaker involvement made possible thanks to the support from  |
||
|
1100-1200 |
Plenary 8 - Psychosocial
Chairs - Gordon Miles/Jordan Hansford Maintaining our capacity to think: Facing and embracing the challenges and distress inherent in our work with children and families. Dr Julie Stone, Child & Family Psychiatrist Ranita Sidhu, Perth Children’s Hospital Speaker involvement made possible thanks to the support from  |
||
|
Ballroom 3 |
|||
|
1200-1300 |
Lunch - Trade Display and Poster Viewing |
||
|
Eucalypt & Mallee |
|||
|
1210-1255 |
Bayer - Lunch Symposium |
||
|
Pathways to Precision: Accelerating Funded Access to Genomic Testing Assoc Prof Antoinette Anazodo Dr. Vivek Rathi Brought to you by Bayer 
|
|||
|
1300-1515 |
Ballroom 1 |
Ballroom 2 |
Eucalypt & Mallee |
|
Concurrent 7 - Solid/CNS Preclinical
Chairs - Matt Dun/ Dinisha Govender For replication repair deficiency: Updates and new concepts for patients with replication repair deficient cancers. Dr Uri Tabori, The Hospital for Sick Kids, Canada Improving survival in high-risk Group 3 and SHH-3 models of medulloblastoma with use of radiosensitising effect of inhibitors of DNA damage response pathway. Dr Hetal Dholaria, Perth Children's Hospital Targeting the Anti-apoptotic Protein BCL2 with Venetoclax Combination Treatment in High-risk Neuroblastoma Dr Alvin Kamili, Children's Cancer Institute Inhibiting cell cycle checkpoints improves the efficacy of chemotherapy in pineoblastoma. Dr Meegan Howlett, Telethon Kids Institute Surgery is a window of opportunity: biomaterial-assisted delivery of immunotherapy reduces local recurrence of soft tissue sarcoma Dr Ben Wylie, Telethon Kids Institute HER2-Chimeric Antigen Receptor T cells show Preclinical Efficacy in Intracranial DMG Models Dr Alexander Davenport, Walter and Eliza Hall Institute Targeting Oncohistones in Cancer Dr Nada Jabado, McGill University, Canada Speaker involvement made possible thanks to the support from
|
Concurrent 8 - Psychosocial/Survivorship/Allied Health
Chairs -Geoff McCowage /Jemma Langer Mental health problems in children with cancer: putting the evidence into context Prof David Coghill, The Royal Children's Hospital, Melbourne Speaker involvement made possible thanks to the support from
Fatigue in Children following Treatment for Acute Lymphoblastic Leukaemia: A Longitudinal Study Dr Cinzia De Luca, The Royal Children's Hospital Melbourne "Burn Out" - An opportunity for action and change Ms Jayne Harrison, Children's Cancer Centre, Royal Childrens Hospital Financial toxicity of paediatric cancer in Australia: A real-time assessment of the financial support needs of families during the cost-of-living crisis Dr Eden Robertson, Redkite Devising a tailored model of care to support procedural distress in paediatric oncology patients Miss Emma Kerr, Queensland Children's Hospital Quality of Life, Family Functioning and the needs for Psyhcosical support After Paediatric Brain Tumour Diagnosis Prof Natalie Bradford, Queensland University of Technology Effect of an online nutrition intervention (Reboot-Kids) on the dietary intake of young childhood cancer survivor’s fruit and vegetable intake: A randomised-controlled trial Dr Amy Lovell, The University of Auckland Longitudinal Trajectories of Parents’ Psychological Wellbeing Following Their Child’s Treatment for Acute Lymphoblastic Leukaemia Dr Michelle Tennant, Murdoch Children's Research Institute Predictors of Communication Difficulties in Children Treated for Brain Tumour: An Observational Study Ms Toni Bird, Sydney Children's Hospital Network Do young people who survive cancer, identify as ‘survivors’? Prevalence and predictors of cancer-related identities among adolescents and young adults following cancer Dr Ursula Sansom-Daly, UNSW Sydney When, and how, should we talk about palliative care concepts with adolescents and young adults with cancer? Results from an international Delphi study. Dr Ursula Sansom-Daly, UNSW Sydney |
Concurrent 9 - Transplant & Cellular Therapy
Chairs - Richard Mitchell/Michelle Ng Navigating Endothelial Injury Maze in Transplant-Associated Thrombotic Microangiopathy Prof Sonata Jodele, Cincinnati Children's Hospital Medical Center, United States Speaker involvement made possible thanks to the support from
Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy Dr Mayank Dhamija, Bristol Royal Hospital For Children Precision gene editing for Fanconi Anemia Dr Lorna Mcleman, Royal Children’s Hospital and St Vincent’s Institute of Medical Research CAR-T Cell Therapy Dr Seong Lin Khaw, Royal Children's Hospital A retrospective audit of medical and allied health service usage by patients treated in the first year of the Royal Children’s Hospital CAR-T program Dr Maria Mccarthy, Murdoch Children's Research Institute Expert Panel Discussion: To be or not to be, that is the question.... Cell therapy in Neuroblastoma Dr Chris Fraser, Queensland Children's Hospital Prof Sonata Jodele, Cincinnati Children's Hospital Medical Center Dr Seong Lin Khaw,The Royal Children's Hospital Melbourne |
|
|
Ballroom 3 |
|||
|
1515-1545 |
Afternoon tea - Trade Display and Poster Viewing |
||
|
Ballroom 1 & 2 |
|||
|
1545-1700 |
When the going gets tough, the tough get......
Chair - Angela Alessandri Panel Discussion Dr Julie Stone, Child & Family Psychiatrist Ranita Sidhu, Perth Children's Hospital Dr Angela Alessandri, Perth Children's Hospital Liz Darch, Perth Children's Hospital Dr Julie Stone and Dr Angela Alessandri involvement made possible thanks to the support from
|
||
|
1700-1715 |
Closing ceremony |
||
|
1900-2400 |
|||
A/Prof Sumit Gupta
Hospital For Sick Children
Dr Angela Alessandri
Perth Children's Hospital
Dr Arnold Paulino
University Of Texas Md Anderson Cancer Center
Dr Julie Stone
Child & Family Psychiatrist
Dr Lucas Moreno Martin Retortillo
Vall D'hebron Hospital
Dr Matthew Ehrhardt
St. Jude Children's Research Hospital
Dr Nada Jabado
McGill University
Dr Phoebe Joy Ho
Institute of Haematology, Royal Prince Alfred Hospital, Head of Department
Dr Seong Lin Khaw
Royal Children's Hospital
Dr Susan Russell
Sydney Children's Hospital
Dr Uri Tabori
The Hospital For Sick Children
Prof Chan Cheah
Sir Charles Gairdner Hospital
Prof Paul Monagle
Professor Paediatrics, University Of Melbourne
Prof Sonata Jodele
Cincinnati Children's Hospital Medical Center
Ranita Sidhu
Perth Children’s Hospital
2022 Annual Scientific Meeting
The pre-ASM nursing workshop is included with the Full ASM Delegate registration type. Space for this workshop is limited and you will need to indicate during the registration process if you would like to attend.
| Venue: Hyde Park Room, Sheraton Grand Hyde Park, Sydney | |||
|---|---|---|---|
|
0900-1700 |
ANZCHOG Nurses Pre Conference Workshop Program |
||
|
|
Chair: Chrissy Hanmore |
||
|
0900-0905 |
Welcome & housekeeping |
||
|
0905-0950
|
The importance of self-care and the impact of the pandemic Dr Justin Baker St Jude Children’s Research Hospital |
||
|
0950-1035
|
Hiding in plain sight. Nursing’s superpower
Prof Mei Krishnasamy Peter MacCallum Cancer Centre |
||
|
1035-1055 |
Morning tea |
||
|
1055-1120 |
Genomics and targeted therapy in childhood cancer Dr Loretta Lau |
||
|
1120-1145 |
Haemophilia overview and what’s the treatment plan for 2022 Grainne Dunne Sydney Children’s Hospital |
||
|
1145-1210 |
Fertility and emerging therapies Tejnei Vaishnav
Royal Hospital for Women, NSW |
||
|
1210-1230 |
The role and value of the research nurse A/Prof Natalie Bradford Queensland University of Technology |
||
|
1230-1300 |
Lunch |
||
|
1300-1430 |
What’s on your eLearning wishlist? eviQ Education showcase and workshop |
||
|
1430-1450 |
The Druggle, Improving Paediatric Oncology Drug Knowledge in Real Time Ms Genevieve Daly |
||
|
1450-1505 |
Afternoon tea |
||
|
1505-1535 |
Navigating end-of-life conversations with adolescents and young adults using the Australian Voicing My Choices tool: best practice & case examples Dr Ursula Samson-Daly, Cath O’Dwyer & Fiona Maguire Sydney Children’s Hospital |
||
|
1535-1605 |
Children and Adolescents with Cancer: Neuropsychological effects, education needs and interventions Dr Soheil Afshar Sydney Children’s Hospital |
||
|
1605-1635 |
Health and wellbeing after cancer: a multidisciplinary program for long-term survivors of childhood malignancies Dr Christina Signorelli, Karen Johnston & Rachael Bell Sydney Children’s Hospital Presented by Dr Jordana McLoone & Rachael Bell |
||
|
1635-1700 |
ANZCHOG Nurses Update, Evaluations and Close |
||
Brought to you by
You will have the option to register your attendance to the Parent Program during the registration process for the ASM.
If you would like to attend the virtual Parent Program only please proceed via the standard registration portal and use registration code*: PAR22 when prompted in order to bypass the ASM registration.
*Please note, by using this code, you will not be registered to attend the ASM or any of the social functions.
Example
|
0930-1510 AEST |
Parent Program |
||
|
|
Chair: Donna Drew |
||
|
0930-0935 |
Welcome and house keeping for virtual attendees |
||
|
0935-0955 |
Keeping up with school during and after childhood cancer
Joanna Fardell |
||
|
0955-1015 |
Managing social challenges during and after childhood cancer
Clarissa Schilstra |
||
|
1015-1030
|
Questions |
||
|
1030-1045 |
Morning tea |
||
|
1045-1115 |
When your child has cancer, goals of care, hope and compassion Justin Baker |
||
|
1115-1145 |
Minimising the psychological impact of cancer treatment on children and adolescents
Liane Willis |
||
|
1145-1215 |
Questions |
||
|
1215-1300 |
Lunch 1240-1300: Lunch session: "Would a national voice from parents lead to improved cancer support for families?" AND "What steps could be taken to build that voice?" A discussion led by Tim Rogers from Redkite |
||
|
|
Chair: Joanna Fardell |
||
|
1300-1320 |
Staying fit and active during and after cancer
Lauren Ha |
||
|
1320-1340 |
Managing the needs of siblings who have a brother or sister with cancer
Brittany McGill |
||
|
1350-1400 |
Afternoon tea |
||
|
1400-1420 |
When and how do I talk to my child about their cancer experience : side effects, experience, fertility
Tali Foreman |
||
|
1420-1440 |
Survivor’s Story: Clarissa will share her story about her cancer diagnosis, relapse, survivorship, academic achievements and being a mum
Clarissa |
||
|
1500-1510 |
Summary of the day & close |
||
The Parent Day program is scheduled in AEST.
Brought to you by
|
0900-0915 |
Opening ceremony |
||
|
0915-1015 |
Plenary 1 |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Improving patient outcomes through integrated paediatric palliative care Dr Justin Baker St Jude Children’s Research Hospital The ASM would like to acknowledge The Kids' Cancer Project for the support of Dr Justin Baker's attendance as an invited speaker.  |
||
|
1015-1045 |
Morning tea - Trade display and poster viewing
|
||
|
1045-1130 |
Plenary 2
|
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Old drugs and new: Still so much to learn about haemostasis in children |
||
|
1130-1215 |
Plenary 3 |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Fertility preservation in young people: The new standard of care Dr Yasmin Jayasinghe Royal Children’s Hospital Melbourne |
||
|
1215-1315 |
Lunch - Trade display and poster viewing |
||
|
1245-1315
|
Partner lunch symposium 1
Transplant related Endotheliopathy: Status Quo of the most significant complications in HSCT |
||
|
|
Location: Hyde Park Room |
||
|
|
Prof Selim Corbacioglu Brought to you by |
||
|
1315-1445 |
Concurrent 1: Non malignant haematology |
Concurrent 2: Translational Medicine |
Concurrent 3: Patient experience |
|
|
Location: Ballroom 1 |
Location: Ballroom 2 |
Location: Hyde Park Room |
|
|
Chair: Prof Paul Monagle Current management of sickle cell disease Dr Anthea Greenway Royal Children's Hospital Melbourne Iron deficiency anaemia Prof Sant-Rayn Parischa Walter and Eliza Hall Institute of Medical Research Transfusion medicine Dr Gemma Crighton Royal Children's Hospital Melbourne |
Chair: Dr Noemi Fuentes Bolanos
Computational Biology in Oncology Drug Discovery A/Prof Antoine de Weck Children's Cancer Institute A Comprehensive Patient-Derived Xenograft Model Platform to Support Translational Neuroblastoma Research Dr Jamie Fletcher Children's Cancer Institute A novel paediatric oncology mouse clinic Ms Zahra Abbas Telethon Kids Institute Targeting the Anti-apoptotic Protein BCL2 With Venetoclax Combination Treatment in High-risk Neuroblastoma Ms Madeleine Wheatley Children's Cancer Institute Exploiting Arginine Addiction to Treat High-Risk Neuroblastoma Dr Kimberley Hanssen Children's Cancer Institute |
Chair: Donna Drew Hoping against hope - Supporting hope in advancing illness Dr Justin Baker St Jude Children's Hospital Memphis The ASM would like to acknowledge The Kids' Cancer Project for the support of Dr Justin Baker's attendance as an invited speaker. ASSET: Collecting patient toxicity data and quality of life data together, where to next? Dr Joanna Fardell Kids Cancer Centre, Sydney Children's Hospital Do long term survivors adhere to recommendations provided by MDT review? Dr Jordana McLoone Kids Cancer Centre, Sydney Children's Hospital Developing a model of care for AYA patients with culturally diverse backgrounds Dr Azhani Amiruddin Crown Princess Mary Cancer Centre |
|
1445-1515 |
Afternoon tea - Trade display and poster viewing |
||
|
1515-1700 |
Concurrent 4: Non malignant haematology |
Concurrent 5: Solid tumours |
Concurrent 6: Patient experience |
|
|
Location: Ballroom 1 |
Location: Ballroom 2 |
Location: Hyde Park Room |
|
|
Chair: Prof Paul Monagle Novel treatments of ITP Current care in haemophilia National guidelines for ITP |
Chair: Dr Felicity Wright
Current therapies in neuroblastoma Dr Toby Trahair Kids Cancer Centre, Sydney Children's Hospital Recruitment principles and strategies for supportive care research in paediatric oncology A/ Prof Natalie Bradford Queensland University of Technology The outcome of paediatric extracranial malignant germ cell tumours: ten years experience of a single institution in Southern Vietnam Dr T. T. An Dao University of Medicine and Pharmacy At Ho Chi Minh City The NCI/COG Molecular Characterisation Project and Zero2 - an update Prof Nick Gottardo Perth Children's Hospital A/Prof Vanessa Tyrrell Children's Cancer Institute |
Chair: Chrissy Hanmore Health workers' understanding of and barriers to palliative care services for Aboriginal children with cancer “Torn in Two” Experiences of mothers who are pregnant when their child is diagnosed with cancer Identifying education and employment outcomes and support needs in Adolescents and Young Adults diagnosed with cancer Fathers’ Experiences of Childhood Cancer Home-Based Hydration for Chemotherapy – Its Clinical Impact and the Experience of Paediatric Oncology Patients and Their Families The management of pain for children hospitalised during Haematopoietic Stem Cell Transplantation |
|
1700-1900 |
Welcome reception |
||
|
0730-0830
|
Partner breakfast 1 CAR-T for ALL IN 2022 |
Partner breakfast 2 Translating guidelines to practice – focus on COVID and IFIs in paediatric haematology and oncology |
|
|
|
Location: Ballroom 1 |
Location: Hyde Park Room |
|
|
|
SeongLin Khaw Brought to you by
|
Chair: Professor Nick Gottardo Dr Brendan McMullan Dr Daniel Yeoh Brought to you by
|
|
|
0900-1000 |
Plenary 4 |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Prof Claire Wakefield You should ask that: The different faces of life after treatment Dr Robert Battisti |
||
|
1000-1030 |
Morning tea - Trade display and poster viewing
|
||
|
1030-1130 |
ANZCHOG 2022 Best abstracts |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Molecular monitoring of ctDNA in neuroblastoma patients for response monitoring and relapse prediction Cardio-oncology guidelines for paediatric oncology patients: A Delphi consensus approach to inform risk stratification, surveillance and management during active cancer therapy. Generation and Multi-Dimensional Profiling of a Childhood Cancer Cell Line Atlas Defines New Therapeutic Opportunities |
||
|
1130-1200 |
ANZCHOG foundations lecture |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Prof Les White A history of paediatric stem cell transplantation in Australia Prof Marcus Vowels |
||
|
1200-1300 |
Lunch - Trade display and poster viewing |
||
|
1225-1255 |
Partner lunch symposium 2 Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer |
||
|
|
Location: Hyde Park Room |
||
|
|
Professor David Ziegler MD Theodore W. Laetsch Brought to you by
|
||
|
1300-1430 |
Concurrent 7: Neuro-oncology |
Concurrent 8: Precision medicine |
Concurrent 9: Global oncology in Oceania: A joint SIOP-ANZCHOG symposium across disciplines |
|
|
Location: Ballroom 2 |
Location: Ballroom 1 |
Location: Hyde Park Room |
|
|
Chair: Dr Neevika Manoharan Holistic care for paediatric brain tumours: 2022 and beyond
Epigenetic regulation of innate signaling in brain tumours: Implications for novel therapeutic approaches. Preliminary Analysis of the Pharmaco-phospho-proteo-genomic Landscape of Paediatric High-grade Gliomas Determining the Clinical Utility of the Immune Modulating Antibody Anti-CD47 in a Preclinical Model of Medulloblastoma. The development of ACT001 as a novel combination therapeutic for diffuse intrinsic pontine gliomas |
Chair: Dr Karen McCleary Precision Medicine 101 High-Throughput Drug Testing on Patient-Derived Models Identifies Novel Rational Treatment Options for Paediatric Cancer Patients Precision medicine is changing the roles of healthcare professionals, scientists, and research staff: Learnings from a childhood cancer precision medicine trial. |
Chairs: Professor Claire Wakefield & Dr Michael Sullivan Improving child cancer care in Oceania, working with the World Health Organisation, and welcome remarks from global leaders Supporting nursing education in Oceania: What’s going on in our neighbourhood? A showcase of child cancer care strengths and challenges in our region, featuring clinicians from Papua New Guinea, Fiji, New Caledonia, Tonga and Timor Leste Discussion and Q&A |
|
1430-1500 |
Afternoon tea - Trade display and poster viewing |
||
|
1500-1630 |
Concurrent 10: Neuro-oncology |
Concurrent 11: Leukaemia/Cellular Therapy |
Concurrent 12: ANZCHOG Trial & Research updates |
|
|
Location: Ballroom 2 |
Location: Ballroom 1 |
Location: Hyde Park Room |
|
|
Chair: Prof Richard Cohn
Long-term control and safety of larotrectinib in a cohort of adult and paediatric patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumours A/ Prof Jordan Hansford Women's and Children's Hospital Adelaide Australasian Methylation Array Profiling – an Update on the AIM BRAIN PROject Dr Christine White Victorian Clinical Genetics Services Characteristics of Children with Brain Cancer: A 10-Year Retrospective Cohort A/ Prof Natalie Bradford Queensland University of Technology Preclinical optimisation of the PI3K/AKT/mTOR inhibitor paxalisib for the treatment of diffuse intrinsic pontine glioma Dr Ryan Duchatel University Of Newcastle |
Chair: Dr Adam Nelson CAR-T cells for B-ALL: Real world data and beyond Cooperative deletions of key lymphoid transcription factors strongly associated with recurrent genomic lesions in B-cell acute lymphoblastic leukaemia Vincristine-Induced Peripheral Neuropathy: Assessing Preventable Strategies in Paediatric Acute Lymphoblastic Leukemia. Reinventing The Wheel - Changing High Dose Methotrexate Habits Chimeric Antigen Receptor (CAR) T cell Therapy: Updated Outcomes at a Single Centre |
Chair: Dr Maria Kirby 1500-1515: Registries, biobanking and supportive care research 1515-1545: Leukaemia/lymphoma and solid tumours clinical trials 1545-1625: CNS clinical trials and ZERO2 initiatives 1625-1630: Trial governance updates |
|
1630-1700 |
Meet the experts 1 Clinical use of asparaginase |
Meet the expert 2 |
|
|
|
Location: Ballroom 1 |
Location: Ballroom 2 |
|
|
|
Dr Siobhan Cross Jessica Nicholson Brought to you by
|
Dr Martin Campbell Dr Aleksandra Wieczorek Brought to you by
|
|
|
1900-2300 |
Gala dinner The Eveleigh, Bay 3, 2 Locomotive St, Eveleigh NSW 2015 |
||
The ASM would like to acknowledge the Robert Connor Dawes Foundation for the support of A/Prof Jordan Hansford's attendance as an invited speaker.
|
0900-1100 |
Panel discussion |
||
|
|
Location: Grand Ballroom |
||
|
|
Moderator: Annabel Crabb ABC journalist Ava’s Journey – Decision making in the age of early phase trials Panelists: Prof David Ziegler, Kids Cancer Centre, Sydney Children's Hospital; Dr Justin Baker, St. Jude Children’s Research Hospital; Prof Mary Chiarella, University of Sydney; Ben Charlton Maryanne Larkin |
||
|
1100-1130 |
Morning tea - Trade display and poster viewing
|
||
|
1130-1230 |
Plenary 5
|
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Communication as a Cornerstone of Care: What We Say and How We Say It Matters
|
||
|
1230-1300 |
Closing ceremony |
||
|
|
Location: Grand Ballroom |
||
|
|
Chair: Dr Richard Mitchell Best abstract awards Thanks for attending ASM 2022 Join us for ASM 2023 |
||
| Day 1 - Thursday 28 July | |||
|---|---|---|---|
|
1245 - 1315 |
Partner Lunch Symposium Transplant related Endotheliopathy: Status Quo of the most significant complications in HSCT |
||
|
|
Prof Selim Corbacioglu Children's Hospital Regensburg Germany Brought to you by  |
||
| Day 2 - Friday 29 July | ||
|---|---|---|
|
0730 - 0830 |
Partner breakfast 1 CAR-T for ALL IN 2022 |
Partner breakfast 2 Translating guidelines to practice – focus on COVID and IFIs in paediatric haematology and oncology |
|
|
SeongLin Khaw Brought to you by
|
Chair: Professor Nick Gottardo Dr Brendan McMullan Dr Daniel Yeoh Brought to you by
|
|
1225 - 1255 |
Partner Lunch Symposium 2 Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer |
|
|
|
Professor David Ziegler MD Theodore W. Laetsch Brought to you by
|
|
|
1630 - 1700 |
Meet the experts 1 Clinical use of asparaginase |
Meet the experts 2 Dinutuximab beta as immunotherapy in high-risk neuroblastoma |
|
|
Dr Siobhan Cross Jessica Nicholson Brought to you by
|
Dr Martin Campbell Dr Aleksandra Wieczorek Brought to you by
|
| Day 2 - Friday 29 July | ||
|---|---|---|
|
0730 - 0830 |
||
|
|
Brought to you by
|
Professor Nick Gottardo Dr Brendan McMullan Dr Daniel Yeoh Brought to you by
|
|
1230 - 1300 |
Partner Lunch Symposium 2 Efficacy and safety of larotrectinib in pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer |
|
|
|
Professor David Ziegler Kids Cancer Centre MD Theodore W. Laetsch Children’s Hospital of Philadelphia/University of Pennsylvania Brought to you by  |
|
|
1630 - 1700 |
Meet the experts 1 Clinical use of asparaginase |
Meet the experts 2 Dinutuximab beta as immunotherapy in high-risk neuroblastoma |
|
|
Dr Siobhan Cross Jessica Nicholson Brought to you by
|
Dr Martin Campbell Royal Children’s Hospital Melbourne Dr Aleksandra Wieczorek University Children’s Hospital, Krakow Brought to you by 
|
Other Invited Speakers
Dr Tina Carter
Perth Children’s Hospital
Janine Furmedge
Royal Children’s Hospital Melbourne
Dr Anthea Greenway
Royal Children’s Hospital Melbourne
Dr Jordana McLoone
Kids Cancer Centre, Sydney Children’s Hospital
Prof Sant-Rayn Parischa
Walter and Eliza Hall Institute of Medical Research
